BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12228883)

  • 1. Estimating disease prevalence in the absence of a gold standard.
    Black MA; Craig BA
    Stat Med; 2002 Sep; 21(18):2653-69. PubMed ID: 12228883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian semi-parametric ROC analysis.
    Erkanli A; Sung M; Costello EJ; Angold A
    Stat Med; 2006 Nov; 25(22):3905-28. PubMed ID: 16416403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian sample-size determination for inference on two binomial populations with no gold standard classifier.
    Stamey JD; Seaman JW; Young DM
    Stat Med; 2005 Oct; 24(19):2963-76. PubMed ID: 16007574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of prior information and stratification for parameter estimation with two screening tests but no gold standard.
    Gustafson P
    Stat Med; 2005 Apr; 24(8):1203-17. PubMed ID: 15558709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian sample size for diagnostic test studies in the absence of a gold standard: Comparing identifiable with non-identifiable models.
    Dendukuri N; Bélisle P; Joseph L
    Stat Med; 2010 Nov; 29(26):2688-97. PubMed ID: 20803558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard.
    Toft N; Innocent GT; Gettinby G; Reid SW
    Prev Vet Med; 2007 May; 79(2-4):244-56. PubMed ID: 17292499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Bayesian prediction of subject disease status and population prevalence using several similar diagnostic tests.
    Evans RB; Erlandson K
    Stat Med; 2004 Jul; 23(14):2227-36. PubMed ID: 15236427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for evaluating the performance of diagnostic tests in the absence of a gold standard: a latent class model approach.
    Garrett ES; Eaton WW; Zeger S
    Stat Med; 2002 May; 21(9):1289-307. PubMed ID: 12111879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating disease prevalence in a Bayesian framework using probabilistic constraints.
    Berkvens D; Speybroeck N; Praet N; Adel A; Lesaffre E
    Epidemiology; 2006 Mar; 17(2):145-53. PubMed ID: 16477254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis using predictive probabilities without cut-offs.
    Choi YK; Johnson WO; Thurmond MC
    Stat Med; 2006 Feb; 25(4):699-717. PubMed ID: 16220514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian estimation for performance measures of two diagnostic tests in the presence of verification bias.
    Aragon DC; Martinez EZ; Achcar JA
    J Biopharm Stat; 2010 Jul; 20(4):821-34. PubMed ID: 20496208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests.
    Dendukuri N; Joseph L
    Biometrics; 2001 Mar; 57(1):158-67. PubMed ID: 11252592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test.
    Dendukuri N; Rahme E; Bélisle P; Joseph L
    Biometrics; 2004 Jun; 60(2):388-97. PubMed ID: 15180664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian latent class models with conditionally dependent diagnostic tests: a case study.
    Menten J; Boelaert M; Lesaffre E
    Stat Med; 2008 Sep; 27(22):4469-88. PubMed ID: 18551515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis.
    Dorny P; Phiri IK; Vercruysse J; Gabriel S; Willingham AL; Brandt J; Victor B; Speybroeck N; Berkvens D
    Int J Parasitol; 2004 Apr; 34(5):569-76. PubMed ID: 15064121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models for estimating bayes factors with applications to phylogeny and tests of monophyly.
    Suchard MA; Weiss RE; Sinsheimer JS
    Biometrics; 2005 Sep; 61(3):665-73. PubMed ID: 16135017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric estimation of ROC curves in the absence of a gold standard.
    Zhou XH; Castelluccio P; Zhou C
    Biometrics; 2005 Jun; 61(2):600-9. PubMed ID: 16011710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.
    Joseph L; Gyorkos TW; Coupal L
    Am J Epidemiol; 1995 Feb; 141(3):263-72. PubMed ID: 7840100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian disease mapping using product partition models.
    Hegarty A; Barry D
    Stat Med; 2008 Aug; 27(19):3868-93. PubMed ID: 18381710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusting for verification bias in diagnostic test evaluation: a Bayesian approach.
    Buzoianu M; Kadane JB
    Stat Med; 2008 Jun; 27(13):2453-73. PubMed ID: 17979150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.